Tirzepatide 5 mg Beligas

£108.00

Tirzepatide 5mg by Beligas represents a dual GLP-1/GIP receptor agonist peptide compound manufactured to research standards. This synthetic peptide enables studies of incretin receptor mechanisms and metabolic pathway modulation in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Tirzepatide 5 mg Beligas
Tirzepatide 5 mg Beligas
£108.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Tirzepatide 5mg Research Overview

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist peptide that has garnered significant attention in metabolic research. This synthetic 39-amino acid peptide demonstrates unique dual incretin receptor activity, making it an invaluable tool for investigating glucose homeostasis mechanisms and energy regulation pathways. Researchers at Stroid UK Shop can access this Beligas-manufactured compound for advanced metabolic studies examining incretin signalling cascades and their downstream effects.

Laboratory Research Applications

In controlled laboratory settings, tirzepatide enables researchers to examine dual incretin receptor activation effects on cellular glucose uptake mechanisms and energy expenditure pathways. Studies have utilised this compound to investigate GLP-1 and GIP receptor crosstalk in pancreatic beta-cell function models and hepatic glucose production regulation. The compound’s unique pharmacological profile allows for sophisticated research into incretin-based therapeutic mechanisms, complementing other metabolic modulators available in our tirzepatide research collection. Laboratory investigations have explored its effects on gastric emptying regulation, appetite signalling pathways, and adipose tissue metabolism in various experimental models, alongside studies comparing its activity to traditional SARM compounds and other research peptides.

Technical Specifications

Tirzepatide 5mg Technical Data
Parameter Specification
Active Compound Tirzepatide
Concentration 5mg per vial
Manufacturer Beligas
Molecular Formula Verify with supplier
CAS Number Verify with supplier
Storage Requirements Lyophilised: -20°C, Reconstituted: 2-8°C
Form Lyophilised powder

Compliance and Research Use

This tirzepatide preparation is manufactured exclusively for in-vitro research applications and laboratory studies. Researchers must ensure proper handling protocols are followed, including appropriate storage conditions and reconstitution procedures. The compound should be utilised only by qualified research personnel in controlled laboratory environments equipped for peptide research. All studies should be conducted in accordance with institutional research guidelines and applicable regulations governing peptide research compounds.

Important: This product is sold strictly for laboratory research purposes only. Not intended for human consumption or therapeutic use.

Related